Javascript must be enabled to continue!
Algorithm for the treatment of advanced proliferative diabetic retinopathy
View through CrossRef
Purpose. To develop an algorithm for the treatment of patients with advanced proliferative diabetic retinopathy with the determination of the stages of laser and surgical methods and evaluate its effectiveness. Material and methods. The study group included 38 patients (38 eyes) with type 1 diabetes mellitus (21 patients) and type 2 diabetes mellitus (17 patients, 16 of them with the insulin-requiring form of the disease). Patients age ranged from 24 to 75 years (41±8.6 years) old. All patients underwent staged treatment. Primary subtotal three-port 27 G vitrectomy was performed. Transpupillary patterned panretinal laser coagulation was performed at 1,5–2 months after the first stage of treatment. Panretinal laser coagulation was performed with a hexagonal matrix pattern with a laser spot diameter of 300 µm, exposure time of 30 ms on an Integre Pro Scan laser device (Ellex, Australia) with a wavelength of 561 nm using a panfundus lens. In cases of gas-air tamponade, panretinal laser coagulation was performed according to the same parameters in two sessions with an interval of 1–2 months between them, the average number of coagulates per session was 1053±107 applications. As the third stage of treatment, 1,5–2 months after panretinal laser coagulation, those patients whose vitreal cavity was tamponed with silicone oil underwent vitrectomy with the removal of silicone oil and it's replacement with a balanced solution. Results. The total number of treatment steps in the observation group (n=34) ranged from 1 to 5 and averaged 3±0.97. The time from primary vitrectomy followed by patterned panretinal laser coagulation to silicone oil removal was at average 3.7±0.48 months. Performing primary subtotal vitrectomy as the first stage of combined treatment made it possible achieve retinal attachment and its visualization throughout, to perform surgical intervention without massive endolaser coagulation, which reduced the duration of surgery and accelerated postoperative rehabilitation. The subsequent transpupillary panretinal laser coagulation of the retina in the pattern mode provided a dosed precision effect on the retina and made it possible perform the laser stage of treatment in one session. Conclusion. A step-by-step algorithm, including primary subtotal vitrectomy followed by simultaneous transpupillary pattern laser coagulation of the retina, is effective and safe in the treatment of proliferative diabetic retinopathy complicated by hemophthalmos. Key words: proliferative diabetic retinopathy, treatment algorithm, surgical treatment, laser treatment, vitrectomy, pattern laser coagulation
Title: Algorithm for the treatment of advanced proliferative diabetic retinopathy
Description:
Purpose.
To develop an algorithm for the treatment of patients with advanced proliferative diabetic retinopathy with the determination of the stages of laser and surgical methods and evaluate its effectiveness.
Material and methods.
The study group included 38 patients (38 eyes) with type 1 diabetes mellitus (21 patients) and type 2 diabetes mellitus (17 patients, 16 of them with the insulin-requiring form of the disease).
Patients age ranged from 24 to 75 years (41±8.
6 years) old.
All patients underwent staged treatment.
Primary subtotal three-port 27 G vitrectomy was performed.
Transpupillary patterned panretinal laser coagulation was performed at 1,5–2 months after the first stage of treatment.
Panretinal laser coagulation was performed with a hexagonal matrix pattern with a laser spot diameter of 300 µm, exposure time of 30 ms on an Integre Pro Scan laser device (Ellex, Australia) with a wavelength of 561 nm using a panfundus lens.
In cases of gas-air tamponade, panretinal laser coagulation was performed according to the same parameters in two sessions with an interval of 1–2 months between them, the average number of coagulates per session was 1053±107 applications.
As the third stage of treatment, 1,5–2 months after panretinal laser coagulation, those patients whose vitreal cavity was tamponed with silicone oil underwent vitrectomy with the removal of silicone oil and it's replacement with a balanced solution.
Results.
The total number of treatment steps in the observation group (n=34) ranged from 1 to 5 and averaged 3±0.
97.
The time from primary vitrectomy followed by patterned panretinal laser coagulation to silicone oil removal was at average 3.
7±0.
48 months.
Performing primary subtotal vitrectomy as the first stage of combined treatment made it possible achieve retinal attachment and its visualization throughout, to perform surgical intervention without massive endolaser coagulation, which reduced the duration of surgery and accelerated postoperative rehabilitation.
The subsequent transpupillary panretinal laser coagulation of the retina in the pattern mode provided a dosed precision effect on the retina and made it possible perform the laser stage of treatment in one session.
Conclusion.
A step-by-step algorithm, including primary subtotal vitrectomy followed by simultaneous transpupillary pattern laser coagulation of the retina, is effective and safe in the treatment of proliferative diabetic retinopathy complicated by hemophthalmos.
Key words: proliferative diabetic retinopathy, treatment algorithm, surgical treatment, laser treatment, vitrectomy, pattern laser coagulation.
Related Results
Diabetic Retinopathy-A Review
Diabetic Retinopathy-A Review
:
Diabetic Retinopathy is a vascular microvascular disease also called diabetic eye disease
caused by microangiopathy leading to progressive damage of the retina and blindness. The...
Karakteristik pasien diabetic retinopathy dengan dislipidemia di RSUP Sanglah Denpasar
Karakteristik pasien diabetic retinopathy dengan dislipidemia di RSUP Sanglah Denpasar
Introduction: Diabetic retinopathy is diabetes mellitus complication which progressively causes microvascular changes in the retina, causing physical and psychosocial impact. Accor...
Association of HbA1c with Diabetic Retinopathy in Diabetic Patients
Association of HbA1c with Diabetic Retinopathy in Diabetic Patients
Background: Retinopathy due to diabetes is increasing in patients due to increase prevalence of diabetes.
Objective : We tried to find if there is any association of HbA1c with Dia...
Gender Specific Distribution Of different patterns of Diabetic Retinopathy In Patients With Type 2 Diabetes Mellitus. A Cross-Sectional Study From a tertiary care specialized center in Lahore, Pakistan
Gender Specific Distribution Of different patterns of Diabetic Retinopathy In Patients With Type 2 Diabetes Mellitus. A Cross-Sectional Study From a tertiary care specialized center in Lahore, Pakistan
BACKGROUND:The patients of diabetic retinopathy are not aware of early retinal vascular dysfunction, which is a feature of diabetic retinopathy.
AIM:This study aimed to detec...
Frequency of Diabetic Retinopathy in Diabetic Patients in Pakistan
Frequency of Diabetic Retinopathy in Diabetic Patients in Pakistan
Objective: To determine the frequency of diabetic retinopathy and its types in diabetic patients of Pakistan.
Study Design: cross sectional study.
Place and duration: study was con...
The Epidemiology and Prevalence of Diabetic Retinopathy in the Veneto Region of North East Italy
The Epidemiology and Prevalence of Diabetic Retinopathy in the Veneto Region of North East Italy
The prevalence of diabetic retinopathy and its relationship to a number of risk factors were examined in a population‐based study in the Veneto region of North East Italy. Of 1321 ...
ASSOCIATION OF MICROALBUMINURIA AND DIABETIC RETINOPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS
ASSOCIATION OF MICROALBUMINURIA AND DIABETIC RETINOPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS
Objectives: Diabetes mellitus (DM) is a long-term metabolic condition marked by decreased synthesis and thereby function of insulin, which can result in serious side effects such a...
Forensic Aspect of Association of Low-density Lipoprotein and Retinopathy in Diabetic Patients
Forensic Aspect of Association of Low-density Lipoprotein and Retinopathy in Diabetic Patients
Introduction: Around 10% of people with diabetes are at risk of losing their eyesight due to diabetic retinopathy,which is a leading cause of blindness globally. Numerous studies h...


